iNtRON Biotechnology, Inc.

₩2,515As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:048530Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (16.36%)
Div yield 3.98%
ROE (11.66%)
Biotechnology
Beta (5Y) 0.15
PE TTM —
TSR TTM (24.25%)
Mkt cap ₩77.69B
ROIC (22.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,010
19.68%
(28.79%)
Hold 5|9|8|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
22.21
23.32
22.45
24.98
1.27%
5.11%
(1.48%)
13.89%
Revenue₩B
3.460
3.666
3.864
3.921
0.81%
8.51%
9.86%
14.86%
Peers (US$57.28M)
Cap (US$)
PE
84.40M
—
49.81M
—
Capital
TTM
5Y
10Y
Leveragex
2.515
0.060
0.069
EBIT/Intx
2.864
0.817
0.650
Own earn%
(101.33)
(9.68)
(3.91)
Sh yield%
31.71
30.11
31.02
Owners
Insiders/Inst%
11.21
38.68
Short interest%
4.09
SBC / revenue%
2.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
25–30
$1 testx
−0.1
Incr. ROIC%
18